Cite
MLA Citation
B. Ylstra et al.. “Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer.” European journal of cancer, vol. 69, n.d., pp. S29–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x000016